NCT07895992
SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study
StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Study First Submitted
Endpoints
Primary
PFS
Timeframe: about 24 months
Secondary (5)
The incidence and grade of adverse events;
OS
ORR
DoR
DCR
Arms and interventions
SHR-A2009 + bevacizumabExperimental
Sacituzumab TirumotecanActive comparator
Drugs: SHR-A2009 + bevacizumab, Sacituzumab Tirumotecan
Sites
1 site in 1 country
- Guangdong Provincial People's HospitalGuangzhou, Guangdong, China